We are live on ! Find out more
IDXX icon

Idexx Laboratories

1,123 hedge funds and large institutions have $29.8B invested in Idexx Laboratories in 2024 Q4 according to their latest regulatory filings, with 165 funds opening new positions, 339 increasing their positions, 439 reducing their positions, and 141 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more first-time investments, than exits

New positions opened: 165 | Existing positions closed: 141

1% more funds holding

Funds holding: 1,1151,123 (+8)

0% more funds holding in top 10

Funds holding in top 10: 1212 (0)

1.33% less ownership

Funds ownership: 89.14%87.82% (-1.3%)

19% less capital invested

Capital invested by funds: $36.7B → $29.8B (-$6.98B)

23% less repeat investments, than reductions

Existing positions increased: 339 | Existing positions reduced: 439

44% less call options, than puts

Call options by funds: $71.7M | Put options by funds: $129M

Holders
1,123
Holders Change
+8
Holders Change %
+0.72%
% of All Funds
14.79%
Holding in Top 10
12
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.16%
New
165
Increased
339
Reduced
439
Closed
141
Calls
$71.7M
Puts
$129M
Net Calls
-$56.9M
Net Calls Change
+$24.1M
Name Holding Trade Value Shares
Change
Change in
Stake
CCA
226
Cobblestone Capital Advisors
New York
$10.1M +$5.26K +12 +0%
Creative Planning
227
Creative Planning
Kansas
$10M -$95.6K -218 -0.9%
Bank of Nova Scotia
228
Bank of Nova Scotia
Ontario, Canada
$9.96M +$6.28M +14,307 +146%
SAM
229
Storebrand Asset Management
Norway
$9.93M -$2.94M -6,709 -22%
CIC
230
Chilton Investment Company
Connecticut
$9.79M -$62.7K -143 -0.6%
ASRS
231
Arizona State Retirement System
Arizona
$9.65M -$143K -327 -1%
X
232
Xponance
Pennsylvania
$9.5M +$1.82M +4,139 +22%
Verition Fund Management
233
Verition Fund Management
Connecticut
$9.44M +$7.16M +16,317 +251%
GC
234
Guggenheim Capital
Illinois
$9.38M -$53.5K -122 -0.5%
Wealth Enhancement Advisory Services
235
Wealth Enhancement Advisory Services
Minnesota
$9.35M -$3.08M -7,012 -24%
HPC
236
HM Payson & Co
Maine
$9.11M -$582K -1,328 -6%
KCM
237
Kornitzer Capital Management
Kansas
$8.95M
PIM
238
Progressive Investment Management
Oregon
$8.81M -$301K -686 -3%
LWM
239
Lyell Wealth Management
California
$8.73M +$31.6K +72 +0.3%
Pathstone Holdings
240
Pathstone Holdings
New Jersey
$8.71M -$1.14M -2,604 -11%
FAF
241
Fjarde Ap-fonden
Sweden
$8.68M +$1.1M +2,500 +14%
ACM
242
Alta Capital Management
Utah
$8.65M -$212K -484 -2%
SBH
243
Segall Bryant & Hamill
Illinois
$8.6M +$9.12M +20,802 New
GIP
244
Granite Investment Partners
California
$8.56M -$780K -1,779 -8%
Axa
245
Axa
France
$8.34M -$13.1M -29,766 -60%
SMDAM
246
Sumitomo Mitsui DS Asset Management
Japan
$8.31M -$1.8M -4,108 -17%
Skandinaviska Enskilda Banken (SEB)
247
Skandinaviska Enskilda Banken (SEB)
Sweden
$7.81M +$833K +1,900 +11%
NAMM
248
NorthStar Asset Management (Massachusetts)
Massachusetts
$7.79M -$26.8K -61 -0.3%
NAM
249
Nissay Asset Management
Japan
$7.75M +$306K +698 +4%
Envestnet Portfolio Solutions
250
Envestnet Portfolio Solutions
Illinois
$7.66M -$26.3K -60 -0.3%

IDXX Hedge Fund Activity: Q4 2024 in Review

1,123 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q4 2024, worth a combined $29.8B — down 19% from $36.7B a quarter earlier.

Buyers outnumbered sellers: 165 funds opened new IDXX positions and 141 closed out — a net gain of 24 holders — while 339 added to existing stakes and 439 trimmed.

The largest buyer was Flossbach Von Storch, adding an estimated $204M. The largest seller was AllianceBernstein, cutting an estimated $692M.

  • 1,123 institutional investors held Idexx Laboratories (IDXX) as of Q4 2024, up from 1,115 in Q3 2024.
  • Funds reported $29.8B of Idexx Laboratories stock for Q4 2024, down 19% quarter-over-quarter.
  • 165 funds opened new Idexx Laboratories positions in Q4 2024 and 141 closed out, a net change of +24 holders.
  • The largest Idexx Laboratories buyer in Q4 2024 was Flossbach Von Storch, an estimated $204M added.
  • The largest Idexx Laboratories seller in Q4 2024 was AllianceBernstein, an estimated $692M sold.

Based on aggregated 13F filings for Q4 2024.